But they say there’s a lot they still don’t know about it, including whether it evades vaccines better or causes more severe disease.
Since mid-November, more than three dozen countries, including Australia, have uploaded nearly 15,000 genetic sequences of BA.2 to GISAID, a global platform for sharing coronavirus data.
It is unclear how prevalent BA.2 is or isn't in Australia. So far there are 96 cases in the US.
The mutant appears much more common in Asia and Europe.
In Denmark, it made up 45 per cent of all COVID-19 cases in mid-January, up from 20 per cent two weeks earlier, according to Statens Serum Institut, which falls under the Danish Ministry of Health.
What do we know about this version of the virus?
BA.2 has lots of mutations.
About 20 of them in the spike protein that studs the outside of the virus are shared with the original Omicron. But it also has additional genetic changes not seen in the initial version.
It's unclear how significant those mutations are, especially in a population that has encountered the original Omicron, said Dr Jeremy Luban, a virologist at the University of Massachusetts Medical School.
For now, the original version, known as BA.1, and BA.2 are considered subsets of Omicron.
But global health leaders could give it its own Greek letter name if it is deemed a globally significant "variant of concern".
The quick spread of BA.2 in some places raises concerns it could take off.
“We have some indications that it just may be as contagious or perhaps slightly more contagious than (original) Omicron since it’s able to compete with it in some areas,” Dr Long said.
"But we don’t necessarily know why that is."
An initial analysis by scientists in Denmark shows no differences in hospitalisations for BA.2 compared with the original Omicron.
Scientists there are still looking into this version's infectiousness and how well current vaccines work against it. It's also unclear how well treatments will work against it.
Doctors also don’t yet know for sure if someone who’s already had COVID-19 caused by Omicron can be sickened again by BA.2.
But they’re hopeful, especially that a prior Omicron infection might lessen the severity of disease if someone later contracts BA.2.
The two versions of Omicron have enough in common that it’s possible that infection with the original mutant "will give you cross-protection against BA.2,” said Dr. Daniel Kuritzkes, an infectious diseases expert at Brigham and Women’s Hospital.
Scientists will be conducting tests to see if antibodies from an infection with the original omicron "are able to neutralise BA.2 in the laboratory and then extrapolate from there," he said.
How concerned are health agencies?
The World Health Organisation classifies Omicron overall as a variant of concern, its most serious designation of a coronavirus mutant, but it doesn’t single out BA.2 with a designation of its own.
Given its rise in some countries, however, the agency says investigations of BA.2 “should be prioritised."
The UK Health Security Agency, meanwhile, has designated BA.2 a “variant under investigation," citing the rising numbers found in the UK and internationally.
Still, the original version of Omicron remains dominant in the UK.
Why is it harder to detect?
The original version of omicron had specific genetic features that allowed health officials to rapidly differentiate it from Delta using a certain PCR test because of what’s known as “S gene target failure.”
BA.2 doesn't have this same genetic quirk. So on the test, Dr Long said, BA.2 looks like Delta.
“It's not that the test doesn't detect it; it's just that it doesn't look like Omicron,” he said.
"Don’t get the impression that ‘stealth omicron’ means we can’t detect it. All of our PCR tests can still detect it.”
What should you do to protect yourself?
Doctors advise the same precautions they have all along: Get vaccinated and follow public health guidance about wearing masks, avoiding crowds and staying home when you’re sick.